Janssen Pharmaceuticals Accused of Hiding Risperdal's Breast Effects In Boys

August 2016

Forbes contributor Emily Willing ham writes "Janssen Pharmaceuticals, Inc., a Johnson & Johnson company that markets this drug as Risperdal, has been accused of hiding evidence back in 2003 that would have alerted clinicians and regulatory authorities to the connection among risperidone, increased prolactin, and gynecomastia."